Search clinical trials for: docetaxel,0xaliplatin,capecitabine

Total 5084 results

Wolfgang Hilbe
Sanofi; Merck Sharp & Dohme LLC; TAKO - Tiroler Arbeitskreis Onkologie

Completed

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

Carcinoma, Non-small-cell Lung

Austria
Eye & ENT Hospital of Fudan University

Active, not recruiting

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Chemotherapy | Immunotherapy | Hypopharyngeal Carcinoma

China
Harbin Medical University

Terminated

Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer (repeat)

Gastric Cancer

China
Hoffmann-La Roche
Sanofi-Synthélabo (Schweiz) AG

Completed

A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Rectal Cancer

Switzerland
Hoffmann-La Roche

Completed

An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer

Colorectal Cancer

Slovakia
Zhejiang University

Suspended

Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM (PSSR)

Surgery | Colorectal Neoplasm | Effects of Chemotherapy | Effects of Radiation Therapy

China
Columbia University

Terminated

GTX Regimen for Biliary Cancers

Biliary Cancer

United States
Ye Xu

Unknown

Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer

Resected Liver Metastases From Colorectal Cancer

China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

Breast Cancer
Ralf Hofheinz
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsche... and other collaborators

Recruiting

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Rectal Cancer

Germany
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Not yet recruiting

JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects

Breast Cancer

China
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

Colorectal Cancer

United States, Canada
RemeGen Co., Ltd.

Recruiting

Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

China
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer

Stage T3-4NxM0 Gastric Cancer

Singapore
Emory University
Sanofi; Georgia Center for Oncology Research & Education

Completed

Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine

Breast Cancer

United States
Charite University, Berlin, Germany

Completed

Docetaxel and Capecitabine in Advanced Gastric Cancer

Neoplasm Metastasis | Stomach Neoplasm

Germany
Shanghai Zhongshan Hospital

Enrolling by invitation

To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.

Gastric Cancer

China
University of California, Irvine
Aventis Pharmaceuticals

Completed

Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer

Cervical Cancer

United States
Ottawa Hospital Research Institute
Sanofi; Hoffmann-La Roche

Withdrawn

IXO+A in mCRC With Liver-only Metastases

Metastatic Colorectal Cancer

Canada
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Withdrawn

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
Adlai Nortye Biopharma Co., Ltd.

Completed

Preoperative Radiotherapy and E7046 in Rectum Cancer (PRAER 1)

Neoadjuvant Therapy in Rectal Cancer

United States, United Kingdom, Poland
National Cancer Institute (NCI)

Terminated

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB... and other conditions

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer

Colorectal Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma

Adenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric Cancer

United States
University of Cologne
Sanofi; Novartis; Roche Pharma AG

Completed

First-line Therapy of Stage IV Colorectal Cancer

Stage IV Colorectal Cancer

Germany
LI XIN-XIANG

Recruiting

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Rectal Neoplasms

China
University of Southern California
Sanofi

Terminated

Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck

Carcinoma of the Head and Neck

United States
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer (RuCorT-01)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Hoosier Cancer Research Network
Sanofi; Hoffmann-La Roche; Walther Cancer Institute

Terminated

Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Columbia University

Completed

Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar

Pancreatic Cancer Stage IVA

United States
Ruijin Hospital

Not yet recruiting

Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer (NeoCHIC)

Colon Cancer

China
China Medical University, China
Liaoning Tumor Hospital & Institute; The First People's Hospital of Jingzhou

Not yet recruiting

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.

Advanced Gastric Carcinoma

Bangladesh
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer (RuCorT-03)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer (RuCorT-02)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Hoffmann-La Roche

Completed

XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

Breast Cancer

United States
Leonard Appleman
Sanofi-Synthelabo

Completed

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Metastatic Transitional Cell Cancer of the Urothelial Tract

United States
US Oncology Research
Genentech, Inc.

Terminated

Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer

Breast Neoplasms | Malignant Tumor of the Breast

United States
Merrimack Pharmaceuticals

Completed

A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer

HER-2 Gene Amplification

United States
Cancer Trials Ireland

Completed

A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer (ELECT)

Gastro Oesophageal Cancer

Ireland
Arbeitsgemeinschaft medikamentoese Tumortherapie
Sanofi; Pfizer; Roche Pharma AG

Completed

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients

Gastric Cancer | Unresectable

Austria
National University Hospital, Singapore

Unknown

The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma

Gastric Cancer

Singapore
Sun Yat-sen University
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer

Gastric Cancer | Locally Advanced Solid Tumor

China
BeiGene

Completed

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma

China
Hebei Medical University

Unknown

Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ，III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma： A Randomized, Controlled Clinical Study

Gastroesophageal Junction Adenocarcinoma

China
Stanford University
Sanofi-Synthelabo

Completed

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

Bladder Cancer

United States
University of Utah

Completed

Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma

Cancer | Pancreas

United States
Fudan University
Shanghai Zhongshan Hospital; RenJi Hospital; First Hospital of China Medical... and other collaborators

Not yet recruiting

Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study

Rectal Cancer | RECTAL NEOPLASMS

Search clinical trials for: docetaxel,0xaliplatin,capecitabine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations